Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263
Authors: Marchioni M.; Kriegmair M.; Heck M.; Amiel T.; Porpiglia F.; Checcucci E.; Campi R.; Minervini A.; Mari A.; Van Bruwaene S.; Linares E.; Hevia V.; Musquera M.; D'Anna M.; Derweesh I.; Bradshaw A.; Autorino R.; Guruli G.; Veccia A.; Roussel E.; Albersen M.; Pavan N.; Claps F.; Antonelli A.; Palumbo C.; Klatte T.; Erdem S.; Carmen Mir M.
